BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25873208)

  • 1. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients.
    Chen Y; Ren W; Zheng D; Zhong J; Liu X; Yue Q; Liu M; Xiao Y; Chen W; Chan Q; Pan J
    J Magn Reson Imaging; 2015 Nov; 42(5):1354-61. PubMed ID: 25873208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging.
    Tu N; Zhong Y; Wang X; Xing F; Chen L; Wu G
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):326-333. PubMed ID: 30630832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel Incoherent Motion-Magnetic Resonance Imaging as an Early Predictor of Treatment Response to Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Xiao Y; Pan J; Chen Y; Chen Y; He Z; Zheng X
    Medicine (Baltimore); 2015 Jun; 94(24):e973. PubMed ID: 26091468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
    Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
    Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
    Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
    Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
    Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
    Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.
    Zhang GY; Wang YJ; Liu JP; Zhou XH; Xu ZF; Chen XP; Xu T; Wei WH; Zhang Y; Huang Y
    Biomed Res Int; 2015; 2015():307943. PubMed ID: 26413513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
    Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
    Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
    Song T; Yao Q; Qu J; Zhang H; Zhao Y; Qin J; Feng W; Zhang S; Han X; Wang S; Yan X; Li H
    Eur Radiol; 2021 Mar; 31(3):1391-1400. PubMed ID: 32901300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
    Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
    Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI.
    Huang WY; Li MM; Lin SM; Chen F; Yang K; Zhu XL; Wu G; Li JJ
    Sci Rep; 2018 Oct; 8(1):15861. PubMed ID: 30367176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion kurtosis imaging for differentiating between the benign and malignant sinonasal lesions.
    Jiang JX; Tang ZH; Zhong YF; Qiang JW
    J Magn Reson Imaging; 2017 May; 45(5):1446-1454. PubMed ID: 27758016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-kurtosis imaging predicts early radiotherapy response in nasopharyngeal carcinoma patients.
    Wu G; Li MM; Chen F; Lin SM; Yang K; Zhao YM; Zhu XL; Huang WY; Li JJ
    Oncotarget; 2017 Sep; 8(39):66128-66136. PubMed ID: 29029498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging.
    Hu F; Tang W; Sun Y; Wan D; Cai S; Zhang Z; Grimm R; Yan X; Fu C; Tong T; Peng W
    Oncotarget; 2017 Sep; 8(43):75597-75606. PubMed ID: 29088894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
    Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
    J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.
    Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
    Clin Imaging; 2020 Oct; 66():127-132. PubMed ID: 32480267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.